1. Home
  2. USNA vs PHAR Comparison

USNA vs PHAR Comparison

Compare USNA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

N/A

Current Price

$17.91

Market Cap

342.7M

Sector

Health Care

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.58

Market Cap

925.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
PHAR
Founded
1992
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
342.7M
925.2M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
USNA
PHAR
Price
$17.91
$12.58
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
109.4K
14.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$1,060,902,000.00
N/A
Revenue This Year
$3.90
$10.04
Revenue Next Year
$6.21
$2.51
P/E Ratio
$42.59
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$16.60
$9.54
52 Week High
$38.32
$21.34

Technical Indicators

Market Signals
Indicator
USNA
PHAR
Relative Strength Index (RSI) 44.52 32.79
Support Level $16.77 $11.84
Resistance Level $18.11 $13.61
Average True Range (ATR) 0.72 0.40
MACD -0.06 0.02
Stochastic Oscillator 29.16 10.88

Price Performance

Historical Comparison
USNA
PHAR

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: